CardiacPatch 

BMES 212- Body Synthetic, Winter 2008 Project

  • Introduction
  • Problem Statement
  • History
  • Current Research
  • Issues to Address
  • Guestbook
  • Team Members
    



W E L C O M E


This website is part of our BMES-212, Body Synthetic, curriculum. The information on this website is a compilation of our research about the CARDIAC PATCH.

The cardiac patch is a form of myocardial tissue engineering.  The cardiac patch is a relatively new and improving field of tissue engineering.  It involves the use of a porous scaffold or dense patch of natural or synthetic polymeric material to aid in the re-growth of heart cells after damage to the heart is sustained.








Cardiovascular disease (CVD) is one of the leading health problems in the world, and is the cause of 26% of all deaths in the Western world.  The main cause of death for patients with CVD is myocardial infarction.  This occurs when the blood supply to a part of the heart is obstructed, resulting in dead or damaged heart tissue.  This dead tissue cannot repair itself and is replaced by scar tissue.  This scar tissue does not have contractile, mechanical or electrical properties of normal heart tissue.  This scar tissue does not behave as efficiently as normal heart tissue and can increase the stress placed on the heart as well as lower the hearts pumping efficiency.  While the heart can temporarily overcome this loss of efficiency, it will eventually lead to heart failure.


Click for larger picture  


   
     Once heart failure has occurred steps need to be taken in order for the patient to survive.  These include heart transplant or ventricular assist devices (VAD).  Unfortunately both of these options are expensive and there are a limited number of heart donors available.  Therefore it is necessary to develop alternative solutions to the problem.  The cardiac patch is one of these solutions.  Previous attempts to solve this have been done using bone marrow cells or embryonic stem cells.  These would be introduced to the dead myocardium.  However, this proved to be inefficient.


                             

    There are two parts to a cardiac patch, the biomaterial scaffold and the myocardium cells.  The biomaterial needs to be able to interact with the cells and promote cell attachment, growth and differentiation.  The biomaterial needs to promote in vivo revasularization as well as encourage integration of the cells with the heart itself. 


    The use of a cardiac patch allows an alternative solution to repairing damaged heart tissue.  Normally a heart transplant or VAD would be used to treat this.  A heart transplant involves replacing your current heart with one from an organ donor.  There are many problems with this.  The number of patients that need a heart transplant exceed the number of donor hearts available.  Also, complications can occur from this surgery such as tissue rejection.  This surgery also requires the patient to be put on immuno repression medicine which can leave the patient at risk to other sicknesses.  VADs were originally designed for temporary use until a donor heart was available.  They work with patients heart to assist a ventrical in its pumping duties.  They can be used for long term use, however are expensive and not always a good long term solution.

    The cardiac patch is unlike the previous two options in that it repairs the damaged myocardial tissue.  Instead of implanting a device or replacing the heart it would now a possibility to fix it.This will enable many more people to be eligible for a procedure to fix complication due to heart disease and myocardial infarction.





Site Counter
business web site builder
Updated by: Neha Bailwal
Template provided by: DesignsByDarren.com